Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $589.80 | 14 | 66.2% |
| Education | $301.19 | 3 | 33.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $581.39 | 9 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $187.72 | 7 | $0 (2017) |
| Shire North American Group Inc | $121.88 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $165.80 | 5 | Teva Pharmaceuticals USA, Inc. ($165.80) |
| 2022 | $88.49 | 1 | Teva Pharmaceuticals USA, Inc. ($88.49) |
| 2019 | $215.90 | 2 | Teva Pharmaceuticals USA, Inc. ($215.90) |
| 2018 | $233.08 | 2 | Shire North American Group Inc ($121.88) |
| 2017 | $187.72 | 7 | Sunovion Pharmaceuticals Inc. ($187.72) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.92 | General |
| Category: Central Nervous System | ||||||
| 06/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Central Nervous System | ||||||
| 06/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Central Nervous System | ||||||
| 04/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.90 | General |
| Category: Central Nervous System | ||||||
| 02/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Central Nervous System | ||||||
| 05/23/2022 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $88.49 | General |
| 09/13/2019 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $101.50 | General |
| 07/23/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $114.40 | General |
| Category: Central Nervous System | ||||||
| 06/12/2018 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.20 | General |
| 05/24/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: CNS | ||||||
| 06/20/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: CNS | ||||||
| 04/13/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $115.47 | General |
| Category: CNS | ||||||
| 04/11/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: CNS | ||||||
| 03/23/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: CNS | ||||||
| 02/21/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: CNS | ||||||
| 01/26/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 52 | $14,483 | $4,793 |
| 2020 | 1 | 30 | 45 | $4,580 | $1,709 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 52 | $14,483 | $4,793 | 33.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 45 | $4,580 | $1,709 | 37.3% |
About Dr. Daniel Ferber, MD
Dr. Daniel Ferber, MD is a Psychiatry healthcare provider based in The Dalles, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073671368.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Ferber, MD has received a total of $890.99 in payments from pharmaceutical and medical device companies, with $165.80 received in 2024. These payments were reported across 17 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($589.80).
As a Medicare-enrolled provider, Ferber has provided services to 41 Medicare beneficiaries, totaling 97 services with total Medicare billing of $6,503. Data is available for 2 years (2020–2022), covering 2 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location The Dalles, OR
- Active Since 12/05/2006
- Last Updated 01/31/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1073671368
Products in Payments
- LATUDA (Drug) $187.72
- Austedo XR (Drug) $165.80
- MYDAYIS (Drug) $121.88
- AUSTEDO (Drug) $114.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.